Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

Thu, 15th Jul 2021 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday afternoon and Thursday morning:

----------

FTSE 100

----------

UBS RAISES HALMA PRICE TARGET TO 3,150 (3,000) PENCE - 'BUY'

----------

UBS RAISES BAE SYSTEMS PRICE TARGET TO 565 (516) PENCE - 'NEUTRAL'

----------

UBS RAISES COMPASS GROUP PRICE TARGET TO 1,550 (1,490) PENCE - 'NEUTRAL'

----------

CITIGROUP RAISES ENTAIN PRICE TARGET TO 2,200 (1,590) PENCE - 'BUY'

----------

CITIGROUP RAISES NATWEST PRICE TARGET TO 265 (250) PENCE - 'BUY'

----------

CITIGROUP CUTS STANDARD CHARTERED PRICE TARGET TO 490 (570) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS HSBC PRICE TARGET TO 480 (490) PENCE - 'BUY'

----------

BERENBERG RAISES ADMIRAL GROUP PRICE TARGET TO 2,938 (2,758) PENCE - 'HOLD'

----------

PMORGAN CUTS AVIVA PRICE TARGET TO 498 (510) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES BARRATT DEVELOPMENTS TARGET TO 860 (850) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES BARRATT PRICE TARGET TO 861 (821) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES COCA-COLA HBC PRICE TARGET TO 3,100 (3,000) PENCE - 'BUY'

----------

FTSE 250

----------

UBS CUTS ROTORK PRICE TARGET TO 365 (370) PENCE - 'NEUTRAL'

----------

UBS CUTS MEGGITT PRICE TARGET TO 473 (491) PENCE - 'NEUTRAL'

----------

UBS RAISES SPECTRIS PRICE TARGET TO 2,750 (2,700) PENCE - 'SELL'

----------

JPMORGAN RAISES SPECTRIS PRICE TARGET TO 2,900 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES DUNELM GROUP PRICE TARGET TO 1,246 (1,215) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 385 (405) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS RAISES ROYAL MAIL PRICE TARGET TO 685 (600) PENCE - 'BUY'

----------

BERENBERG RAISES TULLOW OIL PRICE TARGET TO 50 (45) PENCE - 'HOLD'

----------

CITIGROUP INITIATES LANCASHIRE HOLDINGS WITH 'NEUTRAL' - TARGET 648 PENCE

----------

CITIGROUP INITIATES HISCOX WITH 'NEUTRAL' - TARGET 910 PENCE

----------

CITIGROUP INITIATES BEAZLEY WITH 'BUY'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,560 (1,330) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES GAMMA COMMUNICATIONS TARGET TO 2,000 (1,600) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES DARKTRACE PRICE TARGET TO 700 (580) PENCE - 'BUY'

----------

BERENBERG RAISES DARKTRACE PRICE TARGET TO 750 (525) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.